Instituto do Cancer do Estado de Sao Paulo Octavio Frias de Oliveira Icesp

São Paulo 04501-000

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Cancer (SCLC)

Studies at this site

• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling